Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: A retrospective study

Clinical trials have not fully demonstrated the efficacy and safety of radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer (LA-SCCHN) in patients with cisplatin-ineligible renal dysfunction. Patients who received radiotherapy plus cetuximab for LA-SCCHN at Chiba Unive...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Chiaki, Saeki, Hiromi, Yamamoto, Kohei, Ichikawa, Ayano, Arai, Makoto, Tawada, Akinobu, Suzuki, Takaaki, Takiguchi, Yuichi, Hanazawa, Toyoyuki, Ishii, Itsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258593/
https://www.ncbi.nlm.nih.gov/pubmed/35836484
http://dx.doi.org/10.3892/ol.2022.13271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258593/
https://www.ncbi.nlm.nih.gov/pubmed/35836484
http://dx.doi.org/10.3892/ol.2022.13271

Ejemplares similares